Anzeige
Meldung des Tages: Kupfer im Fokus: Warum US-Projekte jetzt neu gelesen werden

Bio-Techne Aktie News

Aktie
WKN:  A12ENG ISIN:  US09073M1045 US-Symbol:  TECH Branche:  Biotechnologie Land:  USA
66,78 $
+0,92 $
+1,40%
56,520 € 06.02.26
Depot/Watchlist
Marktkapitalisierung *
7,89 Mrd. €
Streubesitz
-
KGV
109,47
Dividende
0,32 $
Dividendenrendite
0,55%
neu: Nachhaltigkeits-Score
46 %
Index-Zuordnung
S&P 500

Bio-Techne News

04.02.26 - PR Newswire
Bio-Techne Releases Second Quarter Fiscal 2026 Results
Bio-​Techne Releases Second Quarter Fiscal 2026 Results PR Newswire
04.02.26 - PR Newswire
Bio-Techne Declares Dividend
Bio-​Techne Declares Dividend PR Newswire
02.02.26 - PR Newswire
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
Bio-​Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative PR Newswire
28.01.26 - PR Newswire
Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers
Bio-​Techne Launches Simple Plex Ultra-​Sensitive Assays on Ella Platform to Enable Femtogram-​Level Detection of Neurological Biomarkers PR Newswire
20.01.26 - PR Newswire
Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results
Bio-​Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results PR Newswire
23.12.25 - PR Newswire
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference
Bio-​Techne to Present at the 2026 J.P. Morgan Healthcare Conference PR Newswire
11.12.25 - PR Newswire
Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology
Bio-​Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology PR Newswire
09.12.25 - PR Newswire
Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis
Bio-​Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-​Throughput Protein Analysis PR Newswire
25.11.25 - PR Newswire
Bio-Techne to Present at Upcoming Investor Conferences
Bio-​Techne to Present at Upcoming Investor Conferences PR Newswire
18.11.25 - PR Newswire
Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
Bio-​Techne Licenses AI-​Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio PR Newswire
06.11.25 - PR Newswire
Bio-Techne to Present at Upcoming Investor Conferences
Bio-​Techne to Present at Upcoming Investor Conferences PR Newswire
05.11.25 - PR Newswire
BIO-TECHNE DECLARES DIVIDEND
BIO-​TECHNE DECLARES DIVIDEND PR Newswire
05.11.25 - PR Newswire
Bio-Techne Releases First Quarter Fiscal 2026 Results
Bio-​Techne Releases First Quarter Fiscal 2026 Results PR Newswire
04.11.25 - PR Newswire
AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients
AI-​Powered Spatial Biology Workflow from Bio-​Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients PR Newswire
03.11.25 - PR Newswire
ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics
ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics PR Newswire
28.10.25 - PR Newswire
Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
Bio-​Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-​Protein Interactions Research PR Newswire
23.10.25 - PR Newswire
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital PR Newswire
15.10.25 - PR Newswire
Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results
Bio-​Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results PR Newswire
09.10.25 - PR Newswire
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
Bio-​Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 PR Newswire
26.09.25 - PR Newswire
Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications
Bio-​Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications PR Newswire

Newssuche

Videos

newspaper
06.02.26 +6,46%
Technical Trading: Gold kurzfristig Long
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »